Healthcare -
Biotechnology - NASDAQ - US
$ 0.26
3.09 %
$ 16.8 M
Market Cap
-0.42
P/E
GLYC - OPERATING INCOME
Operating Income GLYC - GlycoMimetics, Inc.
-39.3 M
LAST VALUE
21.32%
2 YEAR CAGR
5.28%
5 YEAR CAGR
-14.01%
10 YEAR CAGR